Category Archives: News

University of Applied Sciences Leiden is first Hogeschool to join hDMT

University of Applied Sciences Leiden is first Hogeschool to join hDMT. By 1 December 2022 the hDMT Consortium has welcomed Hogeschool Leiden as the 16th partner organization. Peter Lindenburg(l) and Walter Zuijderduin are the representatives in the hDMT Consortium Assembly. The Leiden Centre for Applied Bioscience (LCAB) is the research institute of the Faculty of Science & Technology of the University of Applied Sciences Leiden. The LCAB consists of six research groups, including Genome-based Health, Metabolomics, Metagenomics, Bioinformatics, Applied Microbiology and Food, Health & Innovation. Aim is to conduct practice-oriented research in the field of Bioscience. The LCAB contributes to...

Read more

Lively 6th annual meeting of growing hDMT community

The annual hDMT Consortium meeting on November 25th, chaired by Amalia Dolga (University of Groningen) was a great success. The Studio33 conference room in Amersfoort, in the colors of the hDMT logo, was filled with more than 165 enthusiastic hDMT researchers. After a welcome by Christine Mummery, chair of hDMT,  senior scientists gave interesting lectures about several topics, including the development within hDMT of standardized platforms for Organ-on-Chip, multi-Organ-on-Chip platforms to predict pharmacokinetics, metabolism in Organ-on-Chip models, and the challenges and opportunities that will be addressed in the new hDMT Bone-on-Chip group. Young talents presented their latest results in high...

Read more

hDMT welcomes VU Amsterdam as new partner

Per 1 November 2022 VU Amsterdam has joined hDMT as a new partner.The representatives in the hDMT Consortium Assembly are Richard Jaspers and Astrid Bakker. VU Amsterdam boasts 3 faculties, Faculty of Sciences (FS), Faculty of Behavioral and Movement Sciences (FGB) and the Academic Centre of Dentistry of Amsterdam (ACTA), in which Organ‐on‐Chip technology is developed and applied. These faculties host the following labs/departments with expert facilities and expertise: ACTA ‐ Department of Oral Cell Biology; Faculty of Behavioural and Movement Sciences; Faculty of Sciences ‐ Department of Molecular and Computational Toxicology; Faculty of Sciences ‐ Department of Chemistry and...

Read more

Proefdiervrij Venture Challenge 2023

Following the successful first editions in 2021 & 2022, Proefdiervrij will organize a third edition of the Proefdiervrij Venture Challenge from January 2023 until April 2023. During the Venture Challenge, researchers are guided in setting up a venture plan, in which a scientific breakthrough within the life sciences is converted into a solid business case. In doing so, they learn various skills needed to start or further develop a business. In this way, we want to increase and accelerate the impact of non-animal research on the use of laboratory animals. Are you interested? Please click here for more information on...

Read more

Niels Harlaar (LUMC) wins Hugo van Poelgeest Award

This year the Hugo van Poelgeest Award ( € 3000,-) was won by Niels Harlaar (LUMC). During the Toekomstproef event in Beeld & Geluid Den Haag on November 18th he received the award for his work on the development of new human heart models to replace laboratory animals in heart disease research. The winner of the audience award was Valentina Palacio-Castañeda (Radboudumc). In her non-animal research, she uses Organs-on-Chips to study the application of new therapeutic proteins for the treatment of cancer. The third nominee was Victoria de Leeuw, who is working on an important transition to animal-free safety assessment...

Read more

Thesis Jeroen Stein (LUMC): Advanced tools and methods for modeling cardiovascular disease using human pluripotent stem cells

On November 24th 2022 Jeroen Stein successfully defended his thesis, entitled: ‘Advanced tools and methods for modeling cardiovascular disease using human pluripotent stem cells’ at Leiden University. His research was performed under the supervision of Prof. Mummery, Dr. Milena Bellin and Dr. Valeria Orlova. To advance disease modelling and drug discovery leading to new pharmaceutical options for cardiovascular patients, new in vitro models and quantification methods are needed that improve clinical predictivity. For this purpose several approaches have been explored, ranging from novel co-culture methods to functional read-outs for human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs), in order to bring...

Read more

Impressive progress of SMART Organ-on-Chip project

On 23 and 24 November, the first annual consortium meeting of the national collaborative project ‘SMART Organ-on-Chip’ was held in Eindhoven. This was a great in-person gathering of all 10 participating research groups, 25 partnering companies, institutes, and health organizations, and the industrial advisory board. Even though the project is not even one year underway, the PhD students working in the project enthusiastically presented impressive progress. Throughout the whole meeting, there were lively discussions about the technology, biology and applications/implementation, which resulted in new ideas and collaborative approaches; a theme that was high on the agenda was how the project...

Read more

EUROoCS co-organizes the MPS World Summit 2023

EUROoCS teams up with the Johns Hopkins Center for Alternatives to Animal Testing (CAAT), supported by more than 40 organizations, to organize the Microphysiological Systems World Summit in Berlin from 26-30 June 2023. So in 2023, the MPS World Summit will be held in lieu of a separate EUROoCS Annual Meeting. The EUROoCS Board is looking forward to meeting all members in Berlin! EUROoCS Board members are contributing to the scientific program of the MPS World Summit and are organizing multiple satellite sessions. In addition, they help in fundraising and are members of the hosting committee and scientific advisory board....

Read more

UMD-Catalyst grant for VLCADD research

Signe Mosegaard and Riekelt Houtkooper, Laboratory Genetic Metabolic Diseases, Amsterdam UMC, received a Catalyst grant (€15.000) from United for Metabolic Diseases and Metakids, to develop prime-edited isogenic control lines and skeletal muscle cells derived from hiPSC with very long-chain acyl-CoA dehydrogenase deficiency (VLCADD). Title project: ‘Induced Pluripotent Stem Cells (iPSC) derived muscle models to investigate pathophysiological mechanisms in very long-chain acyl-CoA dehydrogenase deficiency (VLCADD)’ The project is a collaboration with Pim Pijnappel, Erasmus MC, Sabine Fuchs, UMC Utrecht and Anke Tijsen, Department of Experimental Cardiology, Amsterdam UMC. Read more about the project on the UMD website Or have a look...

Read more

EUROoCS 2022 awards for hDMT researchers

The EUROoCS 2022 conference, with more than 500 attendants, was a success thanks to many people who made this possible.The WTC in Grenoble was a beehive of scientists, companies and regulators, flying in and out of the different rooms to listen to interesting talks, discuss results on the posters and enjoy the delicious French food. The dinner in the Stade des Alpes was a very special experience.During these two days it really felt like one big international family, with members of various ages working towards the same goal: to move the Organ-on-Chip technology forward. Congratulations to all 20 prize winners,...

Read more